Project Grant R35GM165823
- The National Institute on Aging awarded the University of New Orleans $149,000 on May 1, 2026, under the Aging Research program (CFDA 93.866) to investigate mechanistic links between elevated reproductive activity and reduced lifespan in Caenorhabditis elegans. The research addresses a gap in understanding how increased reproduction influences somatic aging by studying mated worms with hyperactive germlines. The investigator recently identified hedgehog signaling in mated worms as the first...
- The National Institute of General Medical Sciences awarded the University of Louisville $398,730 on July 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to conduct basic research on lipid regulation of the stem cell niche. The recipient will investigate how changes in lipid metabolism affect stem cell niche homeostasis using Drosophila melanogaster testis as a model system. The research builds on established findings that ectopic lipid accumulation in the...
- The National Institute of General Medical Sciences awarded New York University $125,000 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support a K99/R00 project investigating mitonuclear regulation in Caenorhabditis elegans. The research aims to determine how interactions between mitochondrial and nuclear genomes regulate gene expression and stress responses across tissues. Using natural mitochondrial variation in C. elegans combined with...
- The National Institute of General Medical Sciences awarded The Administrators Of Tulane Educational Fund (Tulane University) $420,750 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate the context-specific functions of the CDK8 kinase module of the Mediator complex. The research addresses how the CDK8-cyclin C complex regulates transcriptional responses to environmental and dietary cues, with specific focus on three questions: how...
- The National Institute of General Medical Sciences awarded the University of New Mexico Health Sciences Center $419,375 on April 1, 2026, to investigate the systemic effects of metabolic enzyme dysfunctions under the Biomedical Research and Research Training program (CFDA 93.859). The recipient will conduct research examining how dysfunctions in D-2-hydroxyglutarate (2HG) metabolism cascade through interconnected biochemical pathways to produce systemic disease. 2HG is an intermediary in...
- The National Institute of General Medical Sciences awarded the University of California, San Diego $440,000 on July 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to conduct research on membrane-protein interactions that control mitochondrial shape and function. The research develops multiscale biophysical tools and computer simulations to integrate molecular details into models of large-scale membrane bending in mitochondria. The work addresses two problem...
- The National Institute of General Medical Sciences awarded the University of North Carolina at Wilmington $546,500 on August 8, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to investigate non-canonical roles of phosphagen kinases in cellular and organismal stress responses. The recipient will use Caenorhabditis elegans as a model system to identify which of three different versions of phosphagen kinases support tolerance to diverse stresses, test whether...
- The National Institute of General Medical Sciences, part of the Department of Health and Human Services National Institutes of Health, awarded New York University $421,737 on March 10, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop data-driven, predictive biophysical models of molecular mechanisms underlying cellular quiescence in microorganisms. The research focuses on quantitative relations between physiological traits and molecular processes in...
- The National Institute of General Medical Sciences awarded Worcester Polytechnic Institute $554,599 on August 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to conduct research on how neuropeptides and monoamines establish sex-specific behavioral responses in the nematode Caenorhabditis elegans. The project will define the mechanisms by which NLP-3 neuropeptides and serotonin modulate a shared neural circuit to create sex-divergent avoidance behavior in...
- The National Institute of General Medical Sciences awarded the University of Maryland Baltimore County $416,456 on August 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support basic research into the genetic and endocrine regulation of multi-organ plasticity and sexually dimorphic behaviors. The research investigates how hormones coordinate physiological responses across multiple organ systems in response to environmental change, with particular focus on...
The National Institute of General Medical Sciences awarded the University of New Orleans $372,500 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859, Assistance Type: Project Grant) to investigate the role of lipid metabolism in germline-soma interactions and stress responses using Caenorhabditis elegans as a model organism. The research examines how increased germline activity—specifically in mated hermaphrodite worms compared to self-fertilized worms—alters lipid metabolism in somatic tissue and influences somatic homeostasis and stress responsiveness. Prior work by the principal investigator found that mated worms experience reduced fat storage, increased susceptibility to osmotic, oxidative, and temperature stresses, and shorter lifespans. The project addresses three major research questions: how an active germline induces somatic loss of neutral lipids and phospholipids; the extent and mechanisms by which germline-induced lipid depletion influences somatic function; and what role lipid metabolism plays in coordinating germline-soma interactions under stress conditions. The period of performance runs from September 1, 2026, through May 31, 2031, with work performed in New Orleans, Louisiana. The award supports basic research under NIGMS's mission to increase understanding of biological processes and lay the foundation for advances in disease diagnosis, treatment, and prevention.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $372.5k | 7/24/26 |